Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3
Closed -$36 1877
2022
Q4
$36 Sell
3
-11
-79% -$193 ﹤0.01% 1797
2022
Q3
$0 Sell
14
-12
-46% -$334 ﹤0.01% 1576
2022
Q2
$1K Hold
26
﹤0.01% 1202
2022
Q1
$1K Buy
26
+8
+44% +$348 ﹤0.01% 1247
2021
Q4
$1K Buy
+18
New +$1.11K ﹤0.01% 1233
2021
Q3
Sell
-28
Closed -$2K 1374
2021
Q2
$2K Buy
28
+24
+600% +$2.19K ﹤0.01% 1003
2021
Q1
$0 Buy
+4
New +$260 ﹤0.01% 1254
2020
Q2
Sell
-36
Closed -$1K 1108
2020
Q1
$1K Buy
+36
New +$857 ﹤0.01% 829

Other funds holding AFMD

Ellevest Inc's AFMD Position: Q1 2023 in Review

Ellevest Inc sold out of Affimed (AFMD) in Q1 2023, closing a stake of 3 shares — an estimated $36 sold.

Ellevest Inc first reported a position in AFMD in Q1 2020 and held it in 8 quarters. The position peaked at $2K in Q2 2021. 94 funds tracked by Wall St. Rank hold AFMD as of Q1 2023.

  • Ellevest Inc reported no remaining Affimed position as of Q1 2023 after selling out during the quarter.
  • Ellevest Inc sold 3 Affimed shares in Q1 2023, an estimated $36.
  • Ellevest Inc first reported a position in Affimed in Q1 2020 and held it in 8 quarters.
  • Ellevest Inc's Affimed position peaked at $2K in Q2 2021.
  • 94 funds tracked by Wall St. Rank held Affimed as of Q1 2023.

Based on Ellevest Inc's 13F filing for Q1 2023, filed 4 May 2023.